<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04072029</url>
  </required_header>
  <id_info>
    <org_study_id>252/17</org_study_id>
    <nct_id>NCT04072029</nct_id>
  </id_info>
  <brief_title>Risk Assessment for Progression to DMEK Following Cataract Surgery in Fuchs Endothelial Corneal Dystrophy</brief_title>
  <official_title>Escala de Riesgo de descompensación Corneal en cirugía de Catarata en Pacientes Con Distrofia Corneal de Fuchs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Justification. Fuchs' corneal endothelial dystrophy (FECD) is one of the main causes of
      corneal transplantation. In many cases, the corneal decompensation derived from this
      dystrophy is triggered as a consequence of cataract surgery, so the dilemma of facing
      isolated cataract surgery or combined with endothelial keratoplasty is often raised.

      Objective. The present study aims to evaluate and select the most important predictive
      factors for corneal decompensation after cataract surgery in patients with FECD.

      Method. Prospective observational study of the preoperative and intraoperative variables
      presumably associated with postoperative corneal edema requiring Descemet stripping
      endothelial keratoplasty (DMEK). Consecutive candidates for cataract surgery with FECD will
      be selected and anterior segment imaging will be performed, along with a complete
      ophthalmological examination. Clinical, pachymetric, tmographic, densitometric, specular
      microscopy, and intraoperative variables will be registered.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Actual">December 30, 2019</completion_date>
  <primary_completion_date type="Actual">December 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of progression to endothelial keratoplasty (DMEK)</measure>
    <time_frame>2 months after cataract surgery</time_frame>
    <description>Evaluation of baseline parameters that could predict the need for DMEK taking into account best espetacle corrected visual acuity and visual symptoms attributable to FECD and corneal edema (worse vision in the mornings, starburst or halos at night or subjective impairment of vision interfering with daily routine activities such as reading printed paper, looking at screens or driving)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Best spectacle corrected visual acuity</measure>
    <time_frame>2 months after cataract surgery</time_frame>
    <description>Measured in logMAR scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal tomography changes</measure>
    <time_frame>2 months after cataract surgery</time_frame>
    <description>Changes in pachymetric parameters (corneal thickness at the apex, center of the pupil, thinnest point and relative pachymetry) and densitometry (central corneal light backscatter) measured by Pentacam Scheimpflug tomograpy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative refraction</measure>
    <time_frame>2 months after cataract surgery and after DMEK surgery</time_frame>
    <description>Postoperative subjective refraction (sphere, cylinder, axis)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">68</enrollment>
  <condition>Fuchs' Endothelial Dystrophy</condition>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Cataract - FECD</arm_group_label>
    <description>Eyes with FECD undergoing cataract surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phacoemulsification with intraocular lens implantation</intervention_name>
    <description>Phacoemulsification (2.2mm coaxial, viscoelastic shield, experienced surgeon) with intraocular lens implantation (acrylic hidrophobic)</description>
    <arm_group_label>Cataract - FECD</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred for cataract surgery to the Cornea Department
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  FECD grade 2 or worse (modified Krachmer scale)

          -  Cataract requiring surgery

          -  Epithelial corneal edema evident in slit lamp examination

        Exclusion Criteria:

          -  Concurrent anterior corneal dystrophy

          -  History of ocular trauma, ocular surgery, previous ocular inflammation or
             infection,uncotroled glaucoma, amblyopia, neovascular age-related macular
             degeneration, or active vacular retinal disease.

          -  Non-collaborative or unable to receive postoperative care at our institution.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francisco Arnalich Montiel, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>H.U. Ramón y Cajal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 22, 2019</study_first_submitted>
  <study_first_submitted_qc>August 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>February 6, 2020</last_update_submitted>
  <last_update_submitted_qc>February 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Fuchs' Endothelial Dystrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

